Actividad expectorante y toxicológica de una formulación elaborada a partir de Eucalyptus globulus Labill, Borago officinalis L, Y Sambucus Nigra L / Expectorant and toxicological activity of a formulation made from Eucalyptus globulus Labill, Borago officinalis L., and Sambucus Nigra L

Introducción: Eucalyptus globulus Labill., (eucalipto), Borago officinalis L. (Borraja) y Sambucus nigra L. (saúco) son especies vegetales de amplio uso popular por sus propiedades antitusígenas y mucolíticas. Objetivo: evaluar los efectos farmacológico y toxicológico de un fitofármaco elaborado con el extracto de la mezcla de las tres plantas. Métodos: a partir de las hojas secas de cada especie, se elaboraron dos extractos fluidos de las tres plantas: E. globulus B. officinalis y S nigra, mezcladas en proporción 25:25:50, respectivamente, se empleó el método de percolación y como disolventes etanol de concentraciones al 30 y 70 por ciento. Para la evaluación del efecto mucolítico se empleó el modelo de Rojo Fenol en secreciones de ratón y se ensayaron los extractos de concentraciones alcohólicas al 30 y 70 por ciento. El estudio toxicológico se realizó al extracto de concentración alcohólica al 70 por ciento. Resultados: en la evaluación farmacológica se encontró que los extractos hidroalcohólicos al 30 y 70 por ciento presentaron efecto mucolítico, con una efectividad ligeramente superior para el extracto en alcohol al 70 por ciento. Cuando se evaluó toxicológicamente, este extracto no presentó efecto tóxico en el ensayo de toxicidad aguda a dosis límite. Conclusiones: las formulaciones elaboradas con los extractos fluidos de las plantas empleando etanol al 30 y 70 por ciento, mostraron efecto mucolítico en el modelo de rojo fenol en secreciones de ratón y con las condiciones experimentales del estudio. El extracto de las plantas en etanol al 70 por ciento no presentó efecto tóxico en el ensayo de toxicidad aguda a dosis límite(AU)

Introduction: Eucalyptus globulus Labill. (eucalyptus), Borago officinalis L. (borage) and Sambucus nigra L. (elder) are plant species commonly used in folk medicine for their antitussive and mucolytic properties. Objective: Evaluate the pharmacological and toxicological effects of a drug made with an extract obtained from a mixture of the three plants. Methods: Two fluid extracts were obtained from dry leaves of the three species, E. globulus, B. officinalis and S. nigra, mixed in a 25:25:50 proportion. The method used was percolation and the solvents were 30 percent and 70 percent ethanol. The mucolytic effect was evaluated with the phenol red model in mouse secretions, and assays were conducted of the 30 percent and 70 percent alcoholic extracts. Toxicological analysis was performed on the 70 percent alcoholic extract. Results: Pharmacological evaluation found that 30 percent and 70 percent hydroalcoholic extracts display a mucolytic effect, effectiveness being slightly higher in the 70 percent alcoholic extract. When evaluated toxicologically, this extract did not show any toxic effect in the dose-limiting acute toxicity test. Conclusions: The formulations developed with fluid plant extracts using 30 percent and 70 percent ethanol were found to have a mucolytic effect in the red phenol model in mouse secretions under experimental test conditions. The 70 percent ethanolic plant extract did not have a toxic effect in the dose-limiting acute toxicity tes(AU)

Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis.

In the course of our continuing search for novel cancer chemopreventive agents from natural sources, several kinds of Eucalyptus plants were screened. Consequently, the phlorogrucinol-monoterpene derivative, euglobal-G1 (EG-1), was obtained from the leaves of Eucalyptus grandis as an active constituent. EG-1 exhibited the remarkable inhibitory effect on two-stage carcinogenesis test of mouse skin tumors induced by 7, 12-dimethylbenz[a]anthracene (DMBA) as an initiator and fumonisin-B1, which has been known as one of mycotoxins produced by Fusarium monifliforme, as a promoter. Further, EG-1 exhibited potent anti-tumor-promoting activity on two-stage carcinogenesis test of mouse pulmonary tumor using 4-nitroquinoline-N-oxide (4-NQO) as an initiator and glycerol as a promoter.

Effect of three programmes for the treatment of endometritis on the reproductive performance of a dairy herd.

Three management programmes to improve the reproductive performance of a dairy herd were compared in a prospective controlled field study on one commercial farm. A total of 542 cows were examined for endometritis 22 to 28 days postpartum and assigned to one of three treatment groups: in group 1 the cows with signs of endometritis were treated with an intrauterine infusion of 100 ml of a 2 per cent polycondensated m-cresolsulphuric acid formaldehyde solution; in group 2 the cows with signs of endometritis were treated with an intrauterine infusion of 125 ml of a 20 per cent eucalyptus compositum solution; and in group 3 all the cows were injected intramuscularly with 0.75 mg of tiaprost, an analogue of prostaglandin F2alpha (PGF2alpha) at two-week intervals, starting on day 43, until they were inseminated. Thirty-four per cent of the cows showed signs of endometritis. In group 3, oestrus detection efficiency was significantly higher than in groups 1 and 2 (P<0.05), the interval to first service was shorter, and the cows had fewer days open than the cows in groups 1 and 2 (P<0.05). The results indicate that management programmes based on the strategic use of PGF2alpha are an effective alternative to traditional programmes based on rectal palpations and intrauterine infusions to control endometritis at a herd level.

The inhibitory effect of funoran and eucalyptus extract-containing chewing gum on plaque formation.

The purpose of this study was to evaluate the inhibitory effect of funoran containing chewing gum (FG) and eucalyptus extract- containing chewing gum (EG) on plaque formation. Fifteen dentists or dental students were assigned a random order of use of either FG, EG or a control gum. All subjects received professional tooth cleanings before the experiment. During the four-day test periods, no oral hygiene measures were allowed other than chewing three pieces of gum for approximately 10 min daily. Chewing gum was used following each morning, noon and evening meal. Plaque formation was evaluated by the Quigley and Hein index. The FG (1.83 +/- 1.1) and EG (1.97 +/- 1.1) significantly reduced plaque compared to the control gum (2.57 +/- 1.2). Our results suggest that FG and EG may be useful in inhibiting dental plaque formation.

[Experience in the use of eucalymine in acute inflammatory ENT diseases in children]. / Opyt primeneniia évkalimina pri ostrykh vospalitel'nykh zabolevaniiakh LOR-organov u detei.

Eucalyptus-based drug eucalymine made in Russia has been tried in children with acute maxillary sinusitis, exacerbation of chronic purulent maxillary sinusitis and peritonsillar abscess. The findings indicate a good antiinflammatory effect of eucalymine which can be used as a treatment of choice in children with ENT diseases.